Xingwang Hu

1.7k total citations
50 papers, 1.2k citations indexed

About

Xingwang Hu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xingwang Hu has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Xingwang Hu's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (6 papers). Xingwang Hu is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (6 papers). Xingwang Hu collaborates with scholars based in China, United States and South Korea. Xingwang Hu's co-authors include Zebing Huang, Xuegong Fan, Chiang J. Li, Andrew C. Keates, Laura Ghisolfi, Xuegong Fan, Dong-ki Lee, Jun Quan, Zhenguo Liu and Yi Kong and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Xingwang Hu

46 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingwang Hu China 20 711 442 208 188 105 50 1.2k
Yajuan Liu China 21 872 1.2× 226 0.5× 234 1.1× 89 0.5× 61 0.6× 59 1.4k
Huafeng Wang China 18 468 0.7× 157 0.4× 195 0.9× 290 1.5× 225 2.1× 30 1.1k
Yi Xie China 21 759 1.1× 279 0.6× 178 0.9× 143 0.8× 204 1.9× 59 1.3k
Hyo-Jong Kim South Korea 11 783 1.1× 186 0.4× 191 0.9× 120 0.6× 138 1.3× 11 1.1k
Lina He United States 18 872 1.2× 315 0.7× 180 0.9× 234 1.2× 107 1.0× 32 1.4k
Xiaobo Guo China 22 880 1.2× 613 1.4× 199 1.0× 105 0.6× 107 1.0× 70 1.3k
Hong Lv China 20 716 1.0× 493 1.1× 192 0.9× 123 0.7× 183 1.7× 85 1.4k
Yanling Zhao China 22 1.0k 1.4× 348 0.8× 385 1.9× 176 0.9× 240 2.3× 48 1.5k
Zhiming Hu China 22 593 0.8× 320 0.7× 439 2.1× 85 0.5× 353 3.4× 93 1.3k

Countries citing papers authored by Xingwang Hu

Since Specialization
Citations

This map shows the geographic impact of Xingwang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingwang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingwang Hu more than expected).

Fields of papers citing papers by Xingwang Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingwang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingwang Hu. The network helps show where Xingwang Hu may publish in the future.

Co-authorship network of co-authors of Xingwang Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingwang Hu. A scholar is included among the top collaborators of Xingwang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingwang Hu. Xingwang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Xiao, Xingwang Hu, & Xuegong Fan. (2023). Competing risk model for prognostic comparison between clear cell type and common type hepatocellular carcinoma: A population‐based propensity score matching study. Cancer Medicine. 12(9). 10406–10422. 3 indexed citations
2.
Pu, Zhangya, Jinghua Liu, Zelong Liu, et al.. (2022). STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment. Cancer Cell International. 22(1). 314–314. 10 indexed citations
3.
Chen, Jun, Min Qi, Xuegong Fan, et al.. (2021). Efficacy of Peginterferon alfa-2b in Nucleoside Analogue Experienced Patients with Negative HBeAg and Low HBsAg: A Non-Randomized Clinical Trial. Infectious Diseases and Therapy. 10(4). 2259–2270. 12 indexed citations
4.
Zhang, Kai, Rui Tian, Ge Wang, et al.. (2020). ADAMTS8 Inhibits Cell Proliferation and Invasion, and Induces Apoptosis in Breast Cancer. SHILAP Revista de lepidopterología. 3 indexed citations
5.
Chen, Jun, Zebing Huang, Xuegong Fan, et al.. (2020). Potential predictors for prognosis and postpartum recovery time of acute fatty liver of pregnancy. BMC Pregnancy and Childbirth. 20(1). 601–601. 5 indexed citations
6.
Chen, Jun, Zebing Huang, Hai Li, et al.. (2020). Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study. Infectious Diseases and Therapy. 10(1). 281–290. 27 indexed citations
7.
Fan, Xuegong, Dan Zhou, Pengcheng Zhou, et al.. (2020). Melittin ameliorates inflammation in mouse acute liver failure via inhibition of PKM2-mediated Warburg effect. Acta Pharmacologica Sinica. 42(8). 1256–1266. 36 indexed citations
8.
Chen, Jun, Zebing Huang, Xingwang Hu, et al.. (2020). LncRNA TP73-AS1/miR-539/MMP-8 axis modulates M2 macrophage polarization in hepatocellular carcinoma via TGF-β1 signaling. Cellular Signalling. 75. 109738–109738. 30 indexed citations
9.
Li, Ning, Juan Wang, Yongming Fu, et al.. (2020). Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma. Clinical Therapeutics. 42(3). 439–447. 15 indexed citations
10.
Wang, Yang, Jun Chen, Yongxiang Tang, et al.. (2020). Cargo-laden erythrocyte ghosts target liver mediated by macrophages. Transfusion and Apheresis Science. 60(1). 102930–102930. 7 indexed citations
11.
Wang, Juan, Ning Li, Zebing Huang, et al.. (2019). HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma. Oncogene. 38(40). 6696–6710. 21 indexed citations
12.
Li, Yajun, Yongming Fu, Xingwang Hu, et al.. (2019). The HBx–CTTN interaction promotes cell proliferation and migration of hepatocellular carcinoma via CREB1. Cell Death and Disease. 10(6). 405–405. 35 indexed citations
13.
Li, Ning, Zebing Huang, Ruochan Chen, et al.. (2018). A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1. Cell Death and Disease. 9(12). 1184–1184. 48 indexed citations
14.
Xiao, Yinzong, Lunquan Sun, Yongming Fu, et al.. (2017). High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo. BMC Cancer. 17(1). 857–857. 14 indexed citations
15.
Tang, Yan, Zhili Deng, Ben Wang, et al.. (2016). Mitochondrial aerobic respiration is activated during hair follicle stem cell differentiation, and its dysfunction retards hair regeneration. PeerJ. 4. e1821–e1821. 46 indexed citations
16.
Ren, Kaiqun, Jing Yuan, Manjun Yang, et al.. (2014). KCTD10 Is Involved in the Cardiovascular System and Notch Signaling during Early Embryonic Development. PLoS ONE. 9(11). e112275–e112275. 27 indexed citations
17.
Hu, Xingwang, Laura Ghisolfi, Andrew C. Keates, et al.. (2012). Induction of cancer cell stemness by chemotherapy. Cell Cycle. 11(14). 2691–2698. 84 indexed citations
18.
Li, Hong, Qian Liu, Xiang Hu, et al.. (2009). Human ZCCHC12 activates AP-1 and CREB signaling as a transcriptional co-activator. Acta Biochimica et Biophysica Sinica. 41(7). 535–544. 12 indexed citations
19.
Huang, Yinhua, Qinghong Liu, Bo Tang, et al.. (2008). A preliminary microsatellite genetic map of the ostrich (<i>Struthio camelus</i>). Cytogenetic and Genome Research. 121(2). 130–136. 13 indexed citations
20.
Hu, Xingwang, et al.. (2003). BMPR1B maps to chromosome 8 in swine. Animal Genetics. 34(4). 306–306. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yajuan Liu Breakdown of academic impact, for papers by Huafeng Wang Breakdown of academic impact, for papers by Yi Xie Breakdown of academic impact, for papers by Hyo-Jong Kim Breakdown of academic impact, for papers by Lina He Breakdown of academic impact, for papers by Xiaobo Guo Breakdown of academic impact, for papers by Hong Lv Breakdown of academic impact, for papers by Yanling Zhao Breakdown of academic impact, for papers by Zhiming Hu
Rankless by CCL
2026